In this article, we will list the 5 Best Get Rich Quick Stocks to Buy Right Now. Please visit 10 Best Get Rich Quick Stocks to Buy Right Now if you would like to see the extended list and the methodology behind it.
5. Hertz Global Holdings, Inc. (NASDAQ:HTZ)
Upside Potential as of July 2, 2026: 135.85%
On June 30, Andrew Percoco from Morgan Stanley trimmed the price target on Hertz Global Holdings, Inc. (NASDAQ:HTZ) to $3.50 from $5 and reaffirmed an Equal Weight rating. The firm has lowered its 2026 adjusted EBITDA estimate by 40%, bringing it to $213 million. This reflects a 2.4% margin, down from the previous projection of $359 million at a 4% margin, due to higher per-unit depreciation.
Morgan Stanley has increased its depreciation per unit estimate for Q2 FY2026 to $300, up from $253, based on the revised guidance from management. With that said, the firm expects increased depreciation per unit to persist through the third and fourth quarters. For the full year 2026, the firm has now raised its projection to $298 from $281.
Antonio Guillem/Shutterstock.com
On June 25, JPMorgan analyst Rajat Gupta stated that the company’s Q2 pre-announcement reflects a stronger-than-expected uptick in net depreciation per unit, associated with softening in the used-car industry. While Hertz Global Holdings, Inc. (NASDAQ:HTZ) delivered the strongest YoY revenue growth in three years in Q1, the stock has delivered negative returns in the past year. But with an upside potential of 135.85%, HTZ remains one of the best get rich quick stocks to buy.
Hertz Global Holdings, Inc. (NASDAQ:HTZ) is a Florida-based vehicle rental company. Founded in 1918, the company operates through the Americas RAC and International RAC segments.
4. FTAI Infrastructure Inc. (NASDAQ:FIP)
Upside Potential as of July 2, 2026: 136.49%
On July 1, Jones Trading started coverage on FTAI Infrastructure Inc. (NASDAQ:FIP) with a Buy rating and a price target of $8.75. As the lowest 1-year price estimate, the firm’s target reflects an upside potential of 97.07% from the current level.
As noted by the analyst, the company is working towards monetizing the Jefferson and Repauno assets. The proceeds from these will likely be redirected toward the rail segment. While highlighting the company’s shift to a short-line freight rail concentration, the firm said that FTAI Infrastructure Inc. (NASDAQ:FIP) shares are trading at “a significant discount to peers.”
During the company’s FY2026 earnings call, management highlighted the agreement to sell Long Ridge to MARA Holdings. Valued at $1.52 billion, the transaction is expected to close in the third quarter. What puts FTAI Infrastructure Inc. (NASDAQ:FIP) in a strong position is its higher cash flow and additional debt capacity, which will help to make investments in the rail sector. With an upside potential of 136.49%, FIP is one of the best get rich quick stocks to invest in.
FTAI Infrastructure Inc. (NASDAQ:FIP) is a New York-based company that acquires and manages assets representing infrastructure. Founded in 2021, the company operates through Railroad, Ports and Terminals, Power and Gas, and Sustainability and Energy Transition segments.
3. EyePoint, Inc. (NASDAQ:EYPT)
Upside Potential as of July 2, 2026: 153.93%
Andreas Argyrides, an analyst at Chardan, significantly lifted the price target on EyePoint, Inc. (NASDAQ:EYPT) to $65 from $29 on July 1. Calling the company “a de-risked, single-asset, catalyst-rich story,” the firm maintained a Buy rating on the shares following a transfer of coverage.
The firm expects readouts from Phase 3 studies of DURAVYU in wet AMD, scheduled for August and October 2026, to be the key catalysts. The two biggest retinal markets, wet AMD and DME, are anticipated to achieve $13 billion in U.S. sales next year, the firm said.
In one year, EyePoint, Inc. (NASDAQ:EYPT) has returned twice as much as the market, with nearly 25% outperformance. Overall, the company has a Buy rating from all twelve analysts covering the stock. With an upside potential of 153.93% based on the one-year median price target of $35.50, EYPT is among the best get rich quick stocks to buy right now.
EyePoint, Inc. (NASDAQ:EYPT) is a Massachusetts-based company specializing in therapeutics for people living with serious retinal diseases. The company’s pipeline is built on its proprietary bioerodible Durasert E technology.
2. Neumora Therapeutics, Inc. (NASDAQ:NMRA)
Upside Potential as of July 2, 2026: 199.40%
On June 18, Mizuho lowered the price target on Neumora Therapeutics, Inc. (NASDAQ:NMRA) to $4, down from $6. This came after the company’s negative Phase 3 KOASTAL-2 and -3 study outcomes. The firm has now removed navacaprant for depression from its financial model.
While highlighting the company’s pipeline, Mizuho reiterated an Outperform rating on Neumora Therapeutics, Inc. (NASDAQ:NMRA). Although still in early stages, the pipeline is “highly intriguing,” the analyst said. The company is developing NMRA-511, which is currently in Phase 1b clinical trials for Alzheimer’s disease agitation, as well as NMRA-861 and NMRA-898.
The firm’s model incorporates contributions from the clinical-stage assets. With that said, Mizuho anticipates critical updates for each program in the latter half of this year. The Street projects an upside potential of 199.40% for Neumora Therapeutics, Inc. (NASDAQ:NMRA), making it one of the best get rich quick stocks to buy right now.
The company also saw price cuts from two other firms. On June 16, Needham trimmed the price target on Neumora Therapeutics, Inc. (NASDAQ:NMRA) to $5 from $8 and reaffirmed a Buy rating. On the same day, H.C. Wainwright also reduced the price target on the company from $18 to $7. The firm maintained a Buy rating.
Neumora Therapeutics, Inc. (NASDAQ:NMRA) is a Massachusetts-based clinical-stage biopharmaceutical company that develops therapeutic solutions for brain diseases, neuropsychiatric disorders, and neurodegenerative diseases.
1. Omeros Corporation (NASDAQ:OMER)
Upside Potential as of July 2, 2026: 374.14%
On June 26, Brandon Folkes from H.C. Wainwright trimmed the price target on Omeros Corporation (NASDAQ:OMER) to $33 from $40 and reaffirmed a Buy rating. This price revision follows a “disappointing” negative CHMP opinion for Yartemlea. While the news is likely to weigh on the stock in the near term, the analyst believes it isn’t entirely “thesis-breaking.”
Folkes views the U.S. Yartemlea launch as a key value driver for Omeros Corporation (NASDAQ:OMER). The price cut is based on the firm’s removal of the EU opportunity from its model and the higher R&D spending guidance.
What’s truly impressive is the company’s one-year return. Omeros Corporation (NASDAQ:OMER) delivered a solid return of 200.32% in contrast to the S&P 500’s return of 20.17%. While the company’s year-to-date performance is negative, its upside potential is approximately 374%. With that, OMER is among the best get rich quick stocks to buy right now.
Omeros Corporation (NASDAQ:OMER), incorporated in 1994, is a Washington-based clinical-stage biopharmaceutical company specializing in small-molecule and protein therapeutics.
While we acknowledge the potential of OMER to grow, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than OMER and that has 100x upside potential, check out our report about the cheapest AI stock.
READ NEXT: Starter Stock Portfolio: 14 Safe Stocks to Buy Now and 40 Most Popular Stocks Among Hedge Funds Heading Into 2026.
Disclosure: None.
